Sihe Zhang | Medicine | Distinguished Scientist Award

Published on by Scientific World Research Awards

Distinguished Scientist Award

Sihe Zhang
Nankai University, China

Sihe Zhang
Affiliation Nankai University
Country China
Scopus ID 7409373738
Documents 55
Citations 1,269
h-index 16
Subject Area Medicine
Event Scientific World Research Awards
ORCID 0000-0002-8923-1993

The Distinguished Scientist Award recognizes the scholarly achievements of Sihe Zhang, Professor and Director at Nankai University School of Medicine. His research focuses on cancer biology, drug delivery systems, endocytosis, extracellular vesicles, antibody therapeutics, and translational medicine. Through sustained contributions to hepatocellular carcinoma and ovarian cancer research, he has developed innovative approaches that connect molecular mechanisms with therapeutic applications.[1]

Abstract

Sihe Zhang is a biomedical researcher whose work spans cancer biology, antibody engineering, cellular uptake mechanisms, extracellular vesicle biology, and targeted therapeutic delivery. His investigations have contributed to understanding macropinocytosis, endocytic recycling, tumor progression, and resistance mechanisms in hepatocellular and ovarian cancers. He has also participated in the development of innovative antibody-based therapies and nanomedicine strategies aimed at improving treatment specificity and efficacy. His publication portfolio demonstrates a sustained commitment to translational medical research and interdisciplinary collaboration, supporting advancements in cancer diagnosis, drug delivery, and precision medicine.[1][2]

Keywords

Cancer Biology; Drug Delivery; Endocytosis; Extracellular Vesicles; Antibody Therapeutics; Hepatocellular Carcinoma; Ovarian Cancer; Nanomedicine.

Introduction

Professor Zhang has held academic positions at Nankai University and previously at the Fourth Military Medical University. His career reflects long-term engagement with molecular medicine and cell biology, emphasizing mechanisms that influence cancer progression and treatment response.[1]

Research Profile

His research profile combines laboratory discovery with translational applications. Major themes include cellular trafficking, therapeutic antibodies, tumor microenvironment studies, and targeted delivery platforms designed to improve treatment outcomes in oncology.[1]

Research Contributions

Notable contributions include investigations into CD147-mediated signaling, extracellular vesicle uptake, macropinocytosis-driven drug resistance, and antibody-based cancer therapies. These studies have expanded understanding of tumor biology and therapeutic targeting strategies.[2][3]

Publications

His scholarly record includes 55 indexed publications. Representative works address hepatocellular carcinoma resistance mechanisms, extracellular vesicle biology, peptide delivery systems, anti-CD147 therapeutics, and nanobiotechnology-based treatment approaches.[2][4]

Research Impact

With 1,269 citations and an h-index of 16, his research has influenced studies in cancer therapeutics, molecular oncology, and biomedical engineering. The impact of his work is reflected through citations, collaborations, and peer-review activities across leading journals.[1]

Award Suitability

The breadth of Professor Zhang’s contributions, combined with sustained publication output and translational relevance, aligns with the objectives of the Scientific World Research Awards. His work demonstrates scientific rigor and practical relevance in medicine.[1]

Conclusion

Sihe Zhang has established a recognized research portfolio in cancer biology and therapeutic innovation. His scholarly achievements and ongoing contributions support recognition through the Distinguished Scientist Award.[1]

References

  1. ORCID. (2026). Sihe Zhang (0000-0002-8923-1993) Research Profile.https://orcid.org/0000-0002-8923-1993
  2. Qian, L., et al. (2025). The uptake of extracellular vesicles: Research progress in cancer drug resistance and beyond. Drug Resistance Updates.https://doi.org/10.1016/j.drup.2025.101209
  3. Qi, F.Z., et al. (2024). Hypoxia-activated ADCC-enhanced humanized anti-CD147 antibody. MedComm.https://doi.org/10.1002/mco2.512
  4. Sun, Z., et al. (2023). Cell-Penetrating Peptide-Based Delivery of Macromolecular Drugs. Biomedicines.https://doi.org/10.3390/biomedicines11071971
  5. Wang, B., et al. (2024). Hypoxia-activated selectivity-improved anti-PKM2 antibody combined with prodrug TH-302. International Journal of Biological Sciences.https://doi.org/10.7150/ijbs.92211

Asterios Deligiannis | Medicine | Best Innovation Award

Published on by Scientific World Research Awards

Best Innovation Award

Asterios Deligiannis

Researcher Information
Affiliation Aristotle University of Thessaloniki
Country Greece
Scopus ID 7003501457
Documents 127
Citations 5,944
h-index 28
Subject Area Chemistry
Event Scientific World Research Awards
ORCID 0000-0001-7765-1897

Asterios Deligiannis is an academic affiliated with Aristotle University of Thessaloniki, Greece. His scholarly record demonstrates extensive research productivity, interdisciplinary collaboration, and sustained scientific contribution. According to available research metrics, he has produced 127 indexed publications, received 5,944 citations, and achieved an h-index of 28, reflecting broad academic visibility and influence across multiple research domains.[1][2]

Abstract

This article presents an overview of the academic achievements of Asterios Deligiannis. His research portfolio encompasses a substantial body of scholarly work, international collaborations, and contributions to scientific knowledge. Available publication metrics indicate 127 indexed documents, 5,944 citations, and an h-index of 28, reflecting sustained research productivity and scholarly influence.[1] His academic activities include participation in international research initiatives, professional organizations, and peer-reviewed publications. These accomplishments demonstrate innovation, research leadership, and measurable scientific impact, supporting consideration for recognition through the Best Innovation Award within an international academic framework.[2]

Keywords

Innovation, Chemistry, Scientific Research, Academic Impact, Research Excellence, Scholarly Contributions.

Introduction

Research innovation is commonly assessed through scientific productivity, influence, and contributions to knowledge development. Academic recognition programs frequently consider publication records, citation performance, and interdisciplinary engagement when evaluating researchers for distinguished awards.[1]

Research Profile

Deligiannis is affiliated with Aristotle University of Thessaloniki and maintains an active ORCID record. His professional activities include academic leadership, international memberships, and participation in collaborative research programs.[2]

Research Contributions

His scholarly contributions span cardiovascular health, exercise-related investigations, rehabilitation studies, and interdisciplinary scientific research. Numerous peer-reviewed publications demonstrate long-term engagement in advancing evidence-based knowledge and innovation.[3]

Publications

The researcher has authored 127 indexed publications and contributed to a broad collection of scientific articles published in international journals. His publication record reflects sustained scholarly activity and extensive collaboration across research communities.[1]

Research Impact

Research influence is demonstrated through 5,944 citations and an h-index of 28. These indicators suggest significant academic visibility and continuing relevance of his publications within scientific literature and research networks.[1]

Award Suitability

The combination of research productivity, scholarly impact, international engagement, and documented scientific contributions supports consideration for the Best Innovation Award. His profile reflects characteristics commonly associated with academic distinction and innovation-oriented recognition.[1]

Conclusion

Asterios Deligiannis has established a substantial academic record characterized by impactful publications, collaborative research activities, and measurable scholarly influence. These achievements provide a strong foundation for recognition within international research award programs.

References

  1. Elsevier. (n.d.). Scopus Author Details: Asterios Deligiannis, Author ID 7003501457. Scopus.

    https://www.scopus.com/authid/detail.uri?authorId=7003501457

  2. ORCID. (2026). Asterios Deligiannis ORCID Record.

    https://orcid.org/0000-0001-7765-1897

  3. Deligiannis, A., et al. (2025). Investigating the Role of Exercise in Improving Bone Health Among Elderly Women with Osteopenia.

    https://doi.org/10.3390/jfmk10040451

  4. Deligiannis, A., et al. (2025). Advanced Stress Echocardiography with Cardiopulmonary Exercise Testing After Myocardial Infarction.

    https://doi.org/10.3390/jfmk10040393

  5. Scientific World Research Awards. (n.d.). Official Award Information Portal.

    https://scientificworld.net/

Yoshiya Tanaka | Medicine | Innovative Research Award

Published on by Scientific World Research Awards

Innovative Research Award

Yoshiya Tanaka

Yoshiya Tanaka
Affiliation Hospital of University of Occupational and Environmental Health
Country Japan
Scopus ID 56328279400
Documents 1,326
Citations 50,831
h-index 99
Subject Area Medicine
Event Scientific World Research Awards

Yoshiya Tanaka, Hospital of University of Occupational and Environmental Health, Japan, is recognized for substantial contributions to rheumatology, immunology, and autoimmune disease research. His scholarly output, clinical investigations, and leadership in international collaborations have supported advancements in evidence-based medical practice and therapeutic development.[1]

Abstract

The Innovative Research Award recognizes researchers whose work demonstrates sustained scientific excellence and measurable impact. Yoshiya Tanaka has contributed extensively to rheumatology and clinical immunology through studies on autoimmune diseases, inflammatory mechanisms, biologic therapies, and targeted treatments. His research has informed clinical guidelines, improved disease classification systems, and supported the development of therapeutic strategies for conditions such as systemic lupus erythematosus, rheumatoid arthritis, and IgG4-related disease. With a substantial publication record and broad international collaboration, his work has influenced both academic research and patient care, reflecting the objectives of the Scientific World Research Awards.[1][2]

Keywords

Rheumatology, Clinical Immunology, Autoimmune Diseases, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Biologic Therapy, Translational Medicine.

Introduction

Modern rheumatology depends on interdisciplinary research linking immunology, molecular biology, and clinical practice. Yoshiya Tanaka has participated in investigations that enhanced understanding of inflammatory pathways and treatment approaches for immune-mediated diseases.[3]

Research Profile

As Professor and Chairman in rheumatology and clinical immunology, Tanaka has developed a research portfolio focused on disease mechanisms, therapeutic innovation, and clinical trial leadership. His scholarly record reflects long-term engagement with translational medicine and global collaboration.[1]

Research Contributions

Key contributions include studies supporting lupus classification criteria, IgG4-related disease frameworks, Janus kinase inhibitor development, and biologic treatment evaluation. These efforts have contributed to improved disease assessment and therapeutic decision-making.[2][4]

Publications

  • 2019 EULAR/ACR Classification Criteria for Systemic Lupus Erythematosus.
  • Trial of Anifrolumab in Active Systemic Lupus Erythematosus.
  • Janus Kinase-Targeting Therapies in Rheumatology.

Research Impact

The researcher’s publications have received extensive citations, demonstrating influence across clinical medicine and immunology. Findings from collaborative studies have informed guidelines, therapeutic development, and evidence-based healthcare practices internationally.[1][5]

Award Suitability

The breadth of scientific output, citation performance, clinical relevance, and leadership in collaborative research aligns with the objectives of the Innovative Research Award. His contributions demonstrate sustained scholarly influence and practical significance in medicine.

Conclusion

Yoshiya Tanaka’s career reflects a consistent commitment to advancing knowledge in rheumatology and autoimmune disease research. His achievements support recognition within international scientific award programs and academic communities.

References

  1. Elsevier. (n.d.). Scopus author details: Yoshiya Tanaka, Author ID 56328279400. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=56328279400
  2. Aringer, M., et al. (2019). 2019 EULAR/ACR Classification Criteria for Systemic Lupus Erythematosus.
    DOI: https://doi.org/10.1002/art.40930
  3. Tanaka, Y., Adams, D.H., & Shaw, S. (1993). T-cell Adhesion Induced by Proteoglycan-Immobilized Cytokine MIP-1β.
    DOI: https://doi.org/10.1038/361079a0
  4. Tanaka, Y., Luo, Y., O’Shea, J.J., & Nakayamada, S. (2022). Janus Kinase-Targeting Therapies in Rheumatology.
    DOI: https://doi.org/10.1038/s41584-021-00726-8
  5. Google Scholar. (2026). Yoshiya Tanaka Citation Profile.
    https://scholar.google.com/citations?user=t_hAg7QAAAAJ&hl=en

Sedanur Güngör | Public Health | Best Researcher Award

Published on by Scientific World Research Awards

Best Researcher Award

Sedanur Güngör

Sedanur Güngör
Affiliation Gazi University
Country Turkey
Scopus ID 59374926100
Documents 4
Citations 5
h-index 1
Subject Area Public Health
Event Scientific World Research Awards
ORCID 0000-0002-3943-5365

Sedanur Güngör is a researcher affiliated with Gazi University whose academic work contributes to the fields of physiotherapy, rehabilitation sciences, and public health. Her scholarly profile includes studies related to hand rehabilitation, telerehabilitation methods, musculoskeletal disorders, and clinical assessment tools.[1] Through collaborative clinical investigations, her research reflects contemporary approaches in rehabilitation practice and patient-centered physiotherapy applications.[2]

Abstract

Sedanur Güngör has developed an emerging academic profile in public health and physiotherapy research through collaborative investigations focusing on rehabilitation sciences and clinical patient outcomes. Her published studies address telerehabilitation, grip strength evaluation, osteoarthritis, tendon repair, and virtual assessment methods in physiotherapy practice.[2] These contributions demonstrate engagement with evidence-based rehabilitation techniques and modern therapeutic technologies. Her scholarly activities also include psychometric and clinical investigations intended to improve patient care and rehabilitation efficiency.[3] The interdisciplinary nature of her work reflects the evolving integration of digital healthcare systems into rehabilitation sciences.

Keywords

Public Health, Physiotherapy, Rehabilitation Sciences, Telerehabilitation, Hand Therapy, Clinical Research

Introduction

Current rehabilitation sciences increasingly incorporate digital assessment methods and patient-centered therapy models. Sedanur Güngör’s research activity aligns with these developments through investigations involving hand rehabilitation and therapeutic evaluation systems.[2]

Research Profile

Her Scopus-indexed publications and ORCID profile document collaborative studies in physiotherapy and rehabilitation medicine. Research topics include tendon repair rehabilitation, osteoarthritis interventions, and psychometric clinical measurements.[1]

Research Contributions

Her published investigations evaluate rehabilitation effectiveness, virtual goniometric measurements, and radial nerve mobilization outcomes in clinical populations.[3] These studies contribute to evidence-based physiotherapy literature.

Publications

Research Impact

The researcher’s contributions support ongoing advancements in rehabilitation assessment and therapeutic monitoring. Her work demonstrates practical relevance for physiotherapy professionals and clinical rehabilitation researchers.[4]

Award Suitability

Sedanur Güngör’s emerging publication profile, interdisciplinary rehabilitation studies, and contributions to clinical physiotherapy research support her recognition for the Best Researcher Award under the Scientific World Research Awards program.[5]

Conclusion

The academic activities of Sedanur Güngör reflect a developing contribution to rehabilitation sciences and public health research through clinically focused physiotherapy investigations and collaborative scholarly work.

References

  1. ORCID. (2026). Sedanur Güngör researcher profile and scholarly works.
    https://orcid.org/0000-0002-3943-5365?lang=en
  2. Elsevier. (n.d.). Scopus author details: Sedanur Güngör, Author ID 59374926100. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=59374926100
  3. Güngör, S., et al. (2026). Virtual goniometric measurement in patients with hand and forearm injuries.
    DOI: https://doi.org/10.1080/09638288.2026.2663904
  4. Güngör, S., et al. (2026). Investigation of the effect of radial nerve mobilization on pain, function, and grip strength.
    DOI: https://doi.org/10.1016/j.physio.2026.102328
  5. Scientific World. (2026). Scientific World Research Awards official website.
    https://scientificworld.net/

Charles Dariane | Medicine | Research Excellence Award

Published on by Scientific World Research Awards

Assist. Prof. Dr. Charles Dariane | Medicine | Research Excellence Award

MD PhD | European Hospital Georges Pompidou | France

Assist. Prof. Dr. Charles Dariane is a leading researcher in urologic oncology, focusing on prostate and renal cancer, advanced imaging, and robotic-assisted surgery. His research skills include clinical trials, surgical innovation, and multidisciplinary collaboration. He has contributed to international cancer guidelines and impactful publications. His Scopus metrics include 1,429 citations, 155 documents, and an h-index of 19. His work enhances precision medicine and improves outcomes in modern urological cancer care.

 

Citation Metrics (Scopus)

1429
1000
700
300
0

Citations

1429

Documents

155

h-index

19

Citations

Documents

h-index

View Scopus Profile

Featured Publications

 

Lina Posada Calderon | Medicine | Research Excellence Award

Published on by Scientific World Research Awards

Dr. Lina Posada Calderon | Medicine | Research Excellence Award

Resident | New York Presbyterian | United States

Dr. Lina Posada Calderon is an accomplished biomedical researcher at Weill Cornell Medicine, New York, specializing in translational and molecular cancer research. Her work focuses on the clinical and molecular characterization of cancers, precision oncology, biomarker discovery, and genetic drivers of tumor progression, with particular emphasis on KRAS-mutated malignancies. She has strong expertise in molecular biology, cancer genomics, clinical data analysis, interdisciplinary research, and high-impact scientific publishing. Her research bridges laboratory discoveries with patient-centered clinical outcomes. Dr. Posada Calderon has published 12 Scopus-indexed documents, receiving 61 citations, and holds an h-index of 5, reflecting her growing scholarly impact and emerging leadership in precision cancer research.

 

Citation Metrics (Scopus)

61
45
30
15
0

Citations

61

Documents

12

h-index

5

Citations

Documents

h-index

View Scopus Profile
 View Google Scholar

Featured Publications

 

Aleksandra Błachnio | Medicine | Research Excellence Award

Published on by Scientific World Research Awards

Prof. Dr. Aleksandra Błachnio | Medicine | Research Excellence Award

Professor | Kazimierz Wielki University | Poland

Prof. Dr. Aleksandra Błachnio is a highly respected scholar in psychology, with a prolific publication record and substantial impact within gerontology, well-being, and social psychology. Her work includes 554 citations, numerous documents (books and articles), and reflects deep commitment to topics such as aging, quality of life in late adulthood, volunteerism among seniors, well-being, life satisfaction across the lifespan, tele-geriatrics, and cross-cultural analysis of psychological health. Her research interests span gerontology and aging psychology, quality-of-life and life-course studies, volunteer activity and social support in old age, psychological adjustment in later life, and mentalization and positive orientation in elderly patients. Among her core research skills are psychometric assessment, longitudinal and cross-sectional survey design, quality-of-life evaluation, social and health psychology methodology, and interdisciplinary analysis of aging and societal change. Her publications such as studies on “health in old age and patient approaches to telemedicine,” “volunteer activity in late adulthood,” and “subjective perception of life-course in old age and youth” showcase her dedication to improving elderly well-being and social inclusion. Her honors include academic recognition as a habilitated doctor in social sciences (psychology), and wide recognition among peers for her contributions to gerontological and social-psychological research. In conclusion, Aleksandra Błachnio stands out as a leading scholar whose enduring research enriches understanding of aging, social participation, and mental health — offering valuable insights for policymakers, healthcare providers, and communities working to enhance quality of life across generations.

Profiles: Scopus | Google Scholar | ResearchGate

Featured Publications

Ziolkowski, A., Blachnio, A., & Pachalska, M. (2015). An evaluation of life satisfaction and health–quality of life of senior citizens. Annals of Agricultural and Environmental Medicine, 22(1). Citations: 47

Litwic-Kaminska, K., Błachnio, A., Kapsa, I., Brzeziński, Ł., Kopowski, J., & others. (2023). Resilience, positivity and social support as perceived stress predictors among university students. International Journal of Environmental Research and Public Health, 20(19), 6892. Citations: 41

Błachnio, A. (2012). Starość non profit. In Wolontariat na Uniwersytetach. Citations: 37

Błachnio, A. (2012). Starość non profit: Wolontariat na Uniwersytetach Trzeciego Wieku w Polsce i na świecie. Wydawnictwo Uniwersytetu Kazimierza Wielkiego. Citations: 37

Błachnio, A. (2019). Potencjał osób w starości: Poczucie jakości życia w procesie starzenia się. Wydawnictwo Uniwersytetu Kazimierza Wielkiego. Citations: 31

Dimitrios Tsiachris | Medicine | Best Researcher Award

Published on by Scientific World Research Awards

Assist. Prof. Dr. Dimitrios Tsiachris | Medicine | Best Researcher Award

EP and Pacing Lab Director | National and Kapodestrian University of Athens | Greece

Dr. D. L. Tsiachris is a highly accomplished cardiovascular researcher and clinician whose work has profoundly influenced the fields of cardiac electrophysiology and interventional cardiology. With an extensive research portfolio encompassing 224 scientific publications, 4,004 citations, and a Scopus h-index of 34, his contributions have advanced the understanding and management of complex cardiac rhythm disorders. His primary research interests lie in atrial fibrillation, ventricular arrhythmias, catheter ablation, and cardiac resynchronization therapy, with particular emphasis on novel energy-based interventions such as pulsed field ablation, cryoballoon technology, and radiofrequency systems. Dr. Tsiachris possesses exceptional research skills in clinical trial design, data synthesis, systematic reviews, and meta-analysis, enabling him to provide robust evidence supporting safer and more effective therapeutic strategies for patients with structural and electrical heart diseases. His investigations into leadless pacing systems, proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, and the optimization of device-based therapies have contributed to personalized and precision-based cardiology. In addition, his studies on patient-reported outcomes and long-term ablation success rates bridge the gap between procedural innovation and patient-centered care. Recognized for his scientific leadership and collaborative excellence, Dr. Tsiachris has co-authored with more than 700 international researchers and continues to influence clinical practice guidelines through his impactful findings. Though his work is primarily published in high-impact journals such as Heart Rhythm, Europace, and Journal of Clinical Medicine, his commitment to advancing cardiovascular science stands as his greatest distinction. Honored for his research excellence and global contributions to electrophysiology, Dr. D. L. Tsiachris remains a driving force in redefining the standards of modern cardiac care through innovation, precision, and evidence-based practice.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

Gatzoulis, K. A., Tsiachris, D., Arsenos, P., et al. (2019). Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: The PRESERVE EF study. European Heart Journal, 40(35), 2940–2949.

Gatzoulis, K. A., Vouliotis, A. I., Tsiachris, D., et al. (2013). Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: Reappraisal of the role of programmed ventricular stimulation. Circulation: Arrhythmia and Electrophysiology, 6(3), 504–512.

Gatzoulis, K. A., Tsiachris, D., et al. (2018). Programmed ventricular stimulation predicts arrhythmic events and survival in hypertrophic cardiomyopathy. International Journal of Cardiology, 254, 175–181.

Silberbauer, J., Tsiachris, D., et al. (2014). Noninducibility and late potential abolition: A novel combined prognostic procedural end point for catheter ablation of postinfarction ventricular tachycardia. Circulation: Arrhythmia and Electrophysiology, 7(3), 424–435.

Della Bella, P., Tsiachris, D., et al. (2013). Management of ventricular tachycardia in the setting of a dedicated unit for the treatment of complex ventricular arrhythmias: Long-term outcome after ablation. Circulation, 127(13), 1359–1368.

Dr. Mokgata A. Matjie’s research advances human resource and organizational management by promoting fairness, emotional intelligence, and performance excellence. His work strengthens institutional effectiveness, employee well-being, and leadership accountability—driving innovation in workplace culture and public sector transformation globally.

Yigit Akin | Medicine | Best Researcher Award

Published on by Scientific World Research Awards

Prof. Dr. Yigit Akin | Medicine | Best Researcher Award

Yigit Akin | Izmir Kâtip Celebi University School of Medicine | Turkey

Professor Yigit Akin is a distinguished urologist and academic leader specializing in uro-oncology, robotic surgery, and minimally invasive laparoscopy. He earned his M.D. from Ege University Faculty of Medicine in 2004 and completed advanced training in robotics, laparoscopy, and uro-oncology at Klinikum Heilbronn, Germany, between 2013 and 2014. Currently, he serves as Head of Urology at Izmir Katip Celebi University, Turkey, leading one of the country’s premier uro-oncology centers. With over 210 peer-reviewed publications, 14 book chapters, and editorial board memberships in international journals, his contributions are well recognized in PubMed and IEEE-indexed forums. He has directed multiple multidisciplinary and international research projects, notably pioneering the extraperitoneal laparoscopic radical prostatectomy using 3 trocars (#3trocarsELRP), with more than 1300 successful procedures. A global mentor in laparoscopic surgery, Prof. Akin has conducted live surgical workshops and training in over 10 countries, while also supervising international clinical fellows. His leadership extends to community-based medical training, editorial contributions, and professional memberships in leading medical and surgical associations. Prof. Akin is strongly positioned to lead next-generation cancer genetics and surgical innovation research. His expertise in developing novel laparoscopic techniques, combined with mentorship of global fellows, demonstrates the potential to advance robotic uro-oncology surgery, elevate Q1 journal contributions, and strengthen international collaborations that will shape the future of minimally invasive urology worldwide.

Profile: ORCID 

Featured Publications

orulmaz, E. M., Dönmez, K., Görgel, S. N., & Akin, Y. (2025). Penil fraktür nedeniyle opere edilen hastaların klinik sonuçları ve komplikasyonlarla ilişkili faktörler: 10 yıllık sonuçlarımız. Androloji Bülteni.

Tekinaslan, H., Görgel, S. N., & Akin, Y. (2025). Malekot kateter kırığına bağlı retroperitoneal yabancı cisim: Nadir bir olgu sunumu. Endouroloji Bülteni.

Dama, M., Yorulmaz, E. M., Özcan, S., Köse, O., Görgel, S. N., & Akin, Y. (2025). AISI, SIRI, and MLR in predicting surgical outcomes after radical cystectomy: Revisiting inflammatory risk markers. Medicina, 61(10), 1756.

Dama, M., Yorulmaz, E. M., Özcan, S., Köse, O., Görgel, S. N., & Akin, Y. (2025). Optimising imaging strategies in suspected urolithiasis: Effects on diagnostic and therapeutic timelines. Harran Üniversitesi Tıp Fakültesi Dergisi.

Özcan, S., Dama, M., Yorulmaz, E. M., Köse, O., Görgel, S. N., & Akin, Y. (2025). Holmium laser enucleation of the prostate and postoperative dysuria: A 20-year bibliometric perspective. Trends in Surgical Sciences.